DE69901843D1 - Eine oder mehrere komponente des perlmuttes einschliesslich bio-aragonit enthaltendes homeopathisches arzneimittel - Google Patents

Eine oder mehrere komponente des perlmuttes einschliesslich bio-aragonit enthaltendes homeopathisches arzneimittel

Info

Publication number
DE69901843D1
DE69901843D1 DE69901843T DE69901843T DE69901843D1 DE 69901843 D1 DE69901843 D1 DE 69901843D1 DE 69901843 T DE69901843 T DE 69901843T DE 69901843 T DE69901843 T DE 69901843T DE 69901843 D1 DE69901843 D1 DE 69901843D1
Authority
DE
Germany
Prior art keywords
aragonite
pearl
mother
components
medicinal product
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69901843T
Other languages
English (en)
Other versions
DE69901843T2 (de
Inventor
Jean-Pierre Lablanchy
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
SCS FRANSSANITO ET CIE, MONACO, MC
Original Assignee
REGENT GENUS ORGANISMUS INTERN
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by REGENT GENUS ORGANISMUS INTERN filed Critical REGENT GENUS ORGANISMUS INTERN
Publication of DE69901843D1 publication Critical patent/DE69901843D1/de
Application granted granted Critical
Publication of DE69901843T2 publication Critical patent/DE69901843T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/56—Materials from animals other than mammals
    • A61K35/618—Molluscs, e.g. fresh-water molluscs, oysters, clams, squids, octopus, cuttlefish, snails or slugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
    • A61K41/0004—Homeopathy; Vitalisation; Resonance; Dynamisation, e.g. esoteric applications; Oxygenation of blood
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Zoology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Organic Chemistry (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
DE69901843T 1998-08-27 1999-08-26 Eine oder mehrere komponente des perlmuttes einschliesslich bio-aragonit enthaltendes homeopathisches arzneimittel Expired - Fee Related DE69901843T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9810857A FR2782641B1 (fr) 1998-08-27 1998-08-27 Medicament homeopathique comprenant un ou plusieurs composants de la nacre
PCT/FR1999/002048 WO2000012104A1 (fr) 1998-08-27 1999-08-26 Medicament homeopathique comprenant un ou plusieurs composants de la nacre dont la bio-aragonite

Publications (2)

Publication Number Publication Date
DE69901843D1 true DE69901843D1 (de) 2002-07-18
DE69901843T2 DE69901843T2 (de) 2003-01-23

Family

ID=9529982

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69901843T Expired - Fee Related DE69901843T2 (de) 1998-08-27 1999-08-26 Eine oder mehrere komponente des perlmuttes einschliesslich bio-aragonit enthaltendes homeopathisches arzneimittel

Country Status (8)

Country Link
US (1) US20020160051A1 (de)
EP (1) EP1107771B1 (de)
AT (1) ATE218876T1 (de)
CA (1) CA2352480A1 (de)
DE (1) DE69901843T2 (de)
ES (1) ES2178461T3 (de)
FR (1) FR2782641B1 (de)
WO (1) WO2000012104A1 (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2946883B1 (fr) * 2009-06-22 2012-04-13 Newco Brevets Produit et procede pour ameliorer la fertilite des mammiferes
WO2012129519A1 (en) 2011-03-23 2012-09-27 Deseret Biologicals, Inc. Formulations of diluted amino acid segments and methods for making same
FR3037801B1 (fr) * 2015-06-23 2017-08-11 Jd Invest Materiau semi-synthetique pulverulent, obtenu par modification de la composition d'un biomateriau naturel marin, son procede de fabrication, ses applications

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH01117833A (ja) * 1987-10-29 1989-05-10 Masatoshi Kato 生物活性物質
FR2742661B1 (fr) * 1995-12-21 1998-07-10 Texinfine Sa Nouvelle utilisation de compositions contenant de la nacre

Also Published As

Publication number Publication date
FR2782641B1 (fr) 2002-05-10
CA2352480A1 (fr) 2000-03-09
EP1107771A1 (de) 2001-06-20
ES2178461T3 (es) 2002-12-16
ATE218876T1 (de) 2002-06-15
US20020160051A1 (en) 2002-10-31
WO2000012104A1 (fr) 2000-03-09
FR2782641A1 (fr) 2000-03-03
DE69901843T2 (de) 2003-01-23
EP1107771B1 (de) 2002-06-12

Similar Documents

Publication Publication Date Title
ATE213164T1 (de) Verwendung von nona- und dekapeptiden zur herstellung eines arzneimittels zur bekämpfung von aids
DK155143C (da) Antioestrogent laegemiddel til behandling af benigne og canceroese tilstande i brystet
HUP0103182A2 (hu) Dialkil-fumarátok alkalmazása transzplantációs kezelésekben használható gyógyászati készítmények előállítására
DE69733132D1 (de) Verwendung von antioxidantien zur behandlung cholestatischer lebererkrankungen
ATE205086T1 (de) Verwendung von dem chelatbildner clioquinol zur herstellung eines arzneimittelszur behandlung von alzheimerschen krankheit
ATE258796T1 (de) Verwendung von vitamin d4-derivaten zur behandlung von hauterkrankungen
ATE415962T1 (de) Verwendung von asiatsäure oder asiaticosid zur behandlung von krebs
ATE249828T1 (de) Verwendung von isatin- und oxindolderivaten zur herstellung von arzeneimittel für die behandlung von mykobakteriellen erkrankungen
MX9708800A (es) Compuestos biciclicos aromaticos.
DE69826023D1 (de) Verwendung von substanzen mit oxytocinwirkung zur herstellung eines arzneimittels zur behandlung affektiver schmerzsyndrome
DE60027209D1 (de) Arzneimittel enthaltend hydroxyapatite zur behandlung von knochengewebserkrankungen
AU5225498A (en) Biaromatic compounds, pharmaceutical and cosmetic compositions containing them and uses thereof
ATE340561T1 (de) Verwendung von antiseptika zur herstellung von arzneimitteln zur prophylaxe und behandlung von entzündungen im korperinneren des menschen
DE69130679D1 (de) Die herstellung von zusammensetzungen zur behandlung von krankheiten der zellproliferation
ATE309817T1 (de) Pharmazeutische zusammensetzung die trkaig2 enthält zur verwendung in der vorbeugung und/oder behandlung von krebs
ATE192923T1 (de) Verwendung von boswelliasäure zur behandlung von hirntumoren
DE69901843D1 (de) Eine oder mehrere komponente des perlmuttes einschliesslich bio-aragonit enthaltendes homeopathisches arzneimittel
ATE400277T1 (de) Pharmazeutische zusammenstellung zur vorbeugung und behandlung von mit zellkrankheiten des augenhintergrundes zusammenhängenden krankheiten
DE50100833D1 (de) Verwendung von 2-methyl-thiazolidin-2,4-dicarbonsäure und / oder ihrer physiologisch verträglichen salze zur herstellung eines medikaments zur behandlung von krebserkrankungen
ATE204759T1 (de) Verwendung von hyperforin und hyperforinhaltigen extrakten zur behandlung und prophylaxe von demenzerkrankungen
MXPA00010254A (es) Tratamiento de disfuncion sexual en ciertos grupos de pacientes.
Shah et al. Trichofolliculoma–'troll hair'dermoscopy.
TR200200278T2 (tr) Kalsilitik bileşimler
ES2110057T3 (es) Composicion medicinal que contiene tcf-ii.
DE59904042D1 (de) Medikament zur prophylaxe und/oder behandlung des mammarkarzinoms enthaltend einen steroidalen aromataseinhibitor

Legal Events

Date Code Title Description
8327 Change in the person/name/address of the patent owner

Owner name: SCS FRANSSANITO ET CIE, MONACO, MC

8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee